| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/16/2002 | WO2002038563A2 Condensed pyrazindione derivatives as pde inhibitors |
| 05/16/2002 | WO2002038561A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 05/16/2002 | WO2002038548A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 05/16/2002 | WO2002038547A1 Quinoline derivatives as nk-3 and nk-2 antagonists |
| 05/16/2002 | WO2002038500A2 Process for the rehydration of magaldrate powder |
| 05/16/2002 | WO2002038160A1 Method for the treatment of inflammation |
| 05/16/2002 | WO2002038156A2 Methods of use of fluoroquinolone compounds against pathogenic helicobacter bacteria |
| 05/16/2002 | WO2002038147A1 Granular drug preparations containing branched amino acids and process for producing the same |
| 05/16/2002 | WO2002038106A2 Calcilytic compounds |
| 05/16/2002 | WO2002026727A3 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 05/16/2002 | WO2002020488A3 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor |
| 05/16/2002 | WO2002019994A3 The treatment of inflammatory disorders |
| 05/16/2002 | WO2002002640A3 Antibodies to human mcp-1 |
| 05/16/2002 | WO2002002090A3 Inhibitors of copper-containing amine oxidases |
| 05/16/2002 | WO2002000593A3 Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
| 05/16/2002 | WO2001098364A3 Peptides, compositions and methods for the treatment of burkholderia cepacia |
| 05/16/2002 | WO2001098291A3 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 05/16/2002 | WO2001085144A3 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione |
| 05/16/2002 | WO2001083547A3 Anti-inflammatory compounds and uses thereof |
| 05/16/2002 | WO2001070663A3 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 05/16/2002 | WO2001070662A3 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 05/16/2002 | WO2001068144A3 Biodegradable immunomodulatory formulations and methods for use thereof |
| 05/16/2002 | WO2001066100A3 Pharmaceutical composition |
| 05/16/2002 | WO2001049654A3 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 05/16/2002 | US20020058839 Methods and compositions for modulating alpha adrenergic receptor activity |
| 05/16/2002 | US20020058809 For therapy of autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, ulcerative colitis, multiple sclerosis, Guillain-Barre syndrome, psoriasis |
| 05/16/2002 | US20020058709 For therapy and prophylaxis of allergic disease of the eye, nose, skin, ear, gastrointestinal tract or lungs |
| 05/16/2002 | US20020058705 For use in therapy of hypercholesterolemia, as anti- ischemic and/or anti-thrombotic agent, as antiplatelet agent, or as agent against gastric ulcers induced by compounds, agents or drugs |
| 05/16/2002 | US20020058700 Ion channel modulating agents |
| 05/16/2002 | US20020058696 Chelate compound-containing antibacterial agent for helicobacter pylori |
| 05/16/2002 | US20020058692 Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
| 05/16/2002 | US20020058687 For therapy and prohylaxis of inflammatory diseases including joint inflammation, Crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (COPD) including asthma, chronic bronchitis |
| 05/16/2002 | US20020058681 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 05/16/2002 | US20020058678 For therapy of diseases or pathological conditions involving inflammation such as chronic inflammatory diseases |
| 05/16/2002 | US20020058652 Pharmaceutical compositions and methods for use |
| 05/16/2002 | US20020058644 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) |
| 05/16/2002 | US20020058635 Purine L-nucleosides, analogs and uses thereof |
| 05/16/2002 | US20020058631 Dipeptide derivatives |
| 05/16/2002 | US20020058630 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 05/16/2002 | US20020058044 LVPs associated with human immunoglobulins having a density of less than 1.063 g/ml. |
| 05/16/2002 | US20020058036 Novel fibroblast growth factor and nucleic acids encoding same |
| 05/16/2002 | US20020058029 Anti-CD40L, anti-B7.1 (CD80), anti-B7.2(CD86), CD40 antibody or anti-CD4 antibody; both may be administered separately or in combination, and in any order. |
| 05/16/2002 | US20020058023 Apoptotic bodies and/or apoptotic cells are in a liquid suspension along with viable cells. |
| 05/16/2002 | US20020058013 Bacterial flora-controlling agent; periodontal-pocket bacterial flora-controlling agent that will eliminate or convert the bacteria, fungi, viruses and other microbes into a group of symbiotic bacteria. |
| 05/16/2002 | CA2428241A1 Novel human potassium channel beta subunit |
| 05/16/2002 | CA2428164A1 Method for the treatment of inflammation |
| 05/16/2002 | CA2428161A1 Substances causing differentiation |
| 05/16/2002 | CA2426730A1 Calcilytic compounds |
| 05/16/2002 | CA2426037A1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | CA2425829A1 Proteases |
| 05/16/2002 | CA2399276A1 Novel therapeutic compositions for treating infection by lawsonia spp |
| 05/15/2002 | EP1205489A1 Polypeptide and nucleic acids encoding the same |
| 05/15/2002 | EP1205478A1 p38MAP KINASE INHIBITORS |
| 05/15/2002 | EP1205191A1 Targeted modification of intracellular compounds |
| 05/15/2002 | EP1204754A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 05/15/2002 | EP1204748A2 New g-protein coupled receptor and dna sequences thereof |
| 05/15/2002 | EP1204747A1 G protein-coupled receptor expressed in brain |
| 05/15/2002 | EP1204665A2 Chemokine receptor antagonists and methods of use therefor |
| 05/15/2002 | EP1204652A1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/15/2002 | EP1204646A1 1,4,5,6 -tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 05/15/2002 | EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 05/15/2002 | EP1204626A1 Ether compounds, compositions, and uses thereof |
| 05/15/2002 | EP1204595A1 Polytype mg-ai hydrotalcite |
| 05/15/2002 | EP1204429A2 Sustained release formulation of a peptide |
| 05/15/2002 | EP1102594B1 Use of sodium chloride to reduce the gastrointestinal toxicity of camptothecin derivatives |
| 05/15/2002 | EP1091659B1 Oral form of administration |
| 05/15/2002 | EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines |
| 05/15/2002 | EP0883622B1 Proton pump inhibitor |
| 05/15/2002 | EP0805813B1 Tricyclic vasopressin antagonists |
| 05/15/2002 | EP0733621B1 Novel imidazole derivative and process for producing the same |
| 05/15/2002 | CN1349537A Cyclic urea and cyclic amide derivatives |
| 05/15/2002 | CN1349527A Substituted benzolactam compounds |
| 05/15/2002 | CN1349523A Novel lipoic acid derivatives, their prepn., and pharmaceutical compositions containing them |
| 05/15/2002 | CN1349521A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 05/15/2002 | CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 05/15/2002 | CN1349504A Piperidine derivatives useful as CCR5 antagonists |
| 05/15/2002 | CN1349500A 3,3-substituted indoline derivatives |
| 05/15/2002 | CN1349499A Thio-oxindole derivatives |
| 05/15/2002 | CN1349496A Caspase inhibitors and the use thereof |
| 05/15/2002 | CN1349418A Compositions for treatment of disorders of the oesophagus |
| 05/15/2002 | CN1349406A Combined preparations comprising morpholine anthracyclines and anticancer agent |
| 05/15/2002 | CN1348815A Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use |
| 05/15/2002 | CN1348814A Chewing table capable of eliminating garlic smell in oral cavity |
| 05/15/2002 | CN1348805A Tonic for women after childbirth and its prepn |
| 05/15/2002 | CN1348804A Male's tonic and its prepn |
| 05/15/2002 | CN1348801A Veterinary medicine for preventing and treating animal's gastrointestinal tract diseases |
| 05/15/2002 | CN1348784A Kangzhi as one orally taken and externally applied medicine |
| 05/15/2002 | CN1348783A Shanbao Oil (contg. plant seed oil and insect power) capsule |
| 05/15/2002 | CN1348776A Nephropathy treating capsule, medicinal powder, tablet, bolus and oral liquid and their prepn |
| 05/15/2002 | CN1348775A Fatty liver treating Chinese medicine |
| 05/15/2002 | CN1348770A Medicine for preventing newborn baby's stomatitis |
| 05/15/2002 | CN1348766A Toothache treating snuff |
| 05/15/2002 | CN1348763A Medicine composite for preventing or treaitng diseases relating to IL-12 over growth |
| 05/15/2002 | CN1084745C Method for preparing 1,3-oxythiapentane and its derivatives |
| 05/15/2002 | CN1084631C Powder medicine made of traditional Chinese medicine and western medicine for treating toothache, and prepn. method therefor |
| 05/15/2002 | CN1084624C Food for improving liver function |
| 05/15/2002 | CN1084618C Use of serotonin antagonists (5HT3) for treatment disease |
| 05/15/2002 | CN1084616C Coatings for tablet of paracetamol and domperidone |
| 05/14/2002 | US6388091 In presence of a halosilane compound; crystallization, purification |
| 05/14/2002 | US6387944 Benzo(b)thiepine-1,1-dioxide derivatives, a method for the production thereof, medicaments containing these compounds, and their use |